[Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma]. 1986

A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda

Fifteen patients operated on for medullary thyroid carcinoma with elevated postoperative serum calcitonin (CT) levels underwent serial measurements of serum CT and carcinoembryonic antigen (CEA) levels. Both CT and CEA levels showed an exponential increase in 12 patients and a slight decrease in three. CEA levels manifested less fluctuation than CT levels. The doubling time of these tumor marker levels calculated from the regression line in each patient showed a strong correlation with three-year survival, recurrence within five years, and the time interval between surgery and recurrence of the tumor, allowing quantitative prediction of the prognosis. However, the doubling time of CEA was longer than that of CT in most patients.

UI MeSH Term Description Entries
D008297 Male Males
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
November 2005, The Journal of clinical endocrinology and metabolism,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
January 1987, Henry Ford Hospital medical journal,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
March 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
February 2008, European journal of endocrinology,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
April 2010, Clinical endocrinology,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
June 2004, Thyroid : official journal of the American Thyroid Association,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
November 2004, Thyroid : official journal of the American Thyroid Association,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
March 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
May 1984, The Journal of clinical endocrinology and metabolism,
A Miyauchi, and T Onishi, and F Matsuzuka, and K Hirai, and K Kuma, and S Takai, and K Nakamoto, and K Nakamura, and S Nanjo, and M Maeda
March 1983, Cancer,
Copied contents to your clipboard!